<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>00841683115243</udiDi>
    <basicUdiDi>008416831363A-1BB</basicUdiDi>
    <tradeName>PAX-8 Rabbit Polyclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>363A-18</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:30:01.003Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683115816</udiDi>
    <basicUdiDi>008416831922PUV</basicUdiDi>
    <tradeName>Trilogy™ Pretreatment Solution</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>HISTOLOGY / CYTOLOGY REAGENTS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>922P-10</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:30:00.989Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683116158</udiDi>
    <basicUdiDi>008416831330M-1BH</basicUdiDi>
    <tradeName>S-100 (4C4.9) Mouse Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>330M-18</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:30:00.977Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683116189</udiDi>
    <basicUdiDi>008416831330M-1BH</basicUdiDi>
    <tradeName>S-100 (4C4.9) Mouse Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>330M-16</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:30:00.964Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683116196</udiDi>
    <basicUdiDi>008416831330M-1BH</basicUdiDi>
    <tradeName>S-100 (4C4.9) Mouse Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>330M-17</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:30:00.945Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683116202</udiDi>
    <basicUdiDi>008416831330M-1BH</basicUdiDi>
    <tradeName>S-100 (4C4.9) Mouse Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>330M-14</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:30:00.929Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683116219</udiDi>
    <basicUdiDi>008416831330M-1BH</basicUdiDi>
    <tradeName>S-100 (4C4.9) Mouse Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>330M-15</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:30:00.910Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683116332</udiDi>
    <basicUdiDi>008416831922PUV</basicUdiDi>
    <tradeName>Trilogy™ Pretreatment Solution</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>HISTOLOGY / CYTOLOGY REAGENTS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>922P-04</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:30:00.897Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683116400</udiDi>
    <basicUdiDi>008416831922PUV</basicUdiDi>
    <tradeName>Trilogy™ Pretreatment Solution</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>HISTOLOGY / CYTOLOGY REAGENTS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>922P-07</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:30:00.876Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683117339</udiDi>
    <basicUdiDi>008416831922PUV</basicUdiDi>
    <tradeName>Trilogy™ Pretreatment Solution</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>HISTOLOGY / CYTOLOGY REAGENTS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>922P-06</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:30:00.865Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683117377</udiDi>
    <basicUdiDi>008416831462R-1E6</basicUdiDi>
    <tradeName>SF-1 (EP434) Rabbit Monoclonal Primary Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>462R-15</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:30:00.856Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683117902</udiDi>
    <basicUdiDi>008416831462R-1E6</basicUdiDi>
    <tradeName>SF-1 (EP434) Rabbit Monoclonal Primary Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>462R-14</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:30:00.846Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683117971</udiDi>
    <basicUdiDi>008416831416M-1CJ</basicUdiDi>
    <tradeName>p16INK4A (JC2) Mouse Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>416M-18</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:30:00.834Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683117988</udiDi>
    <basicUdiDi>008416831416M-1CJ</basicUdiDi>
    <tradeName>p16INK4A (JC2) Mouse Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>416M-15</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:30:00.823Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683118138</udiDi>
    <basicUdiDi>008416831456R-3ET</basicUdiDi>
    <tradeName>IDH1 R132H (MRQ-67) Rabbit Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>456R-38</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:30:00.810Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683118329</udiDi>
    <basicUdiDi>008416831922PUV</basicUdiDi>
    <tradeName>Trilogy™ Pretreatment Solution</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>HISTOLOGY / CYTOLOGY REAGENTS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>922P-05</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:30:00.796Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683118596</udiDi>
    <basicUdiDi>008416831416M-1CJ</basicUdiDi>
    <tradeName>p16INK4A (JC2) Mouse Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>416M-16</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:30:00.785Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683118640</udiDi>
    <basicUdiDi>008416831416M-1CJ</basicUdiDi>
    <tradeName>p16INK4A (JC2) Mouse Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>416M-10</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:30:00.773Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683118725</udiDi>
    <basicUdiDi>008416831456R-3ET</basicUdiDi>
    <tradeName>IDH1 R132H (MRQ-67) Rabbit Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>456R-34</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:30:00.762Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683119258</udiDi>
    <basicUdiDi>008416831760-48973P</basicUdiDi>
    <tradeName>GATA3 (L50-823) Mouse Monoclonal Primary Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>760-4897</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:30:00.752Z</lastUpdated>
  </row>
</eudamedExport>